Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe
Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
European Medicine Agency (
EMA accepts Intas Pharma’s MAA for DMB-3115
herapeutic equivalence and safety confirmed between DMB-3115 and Stelara in global phase III